Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

That business aspect to all this will not be the determining factor. Giants GM Joe Schoen spoke at a press conference Tuesday ...

This was the stock's fifth consecutive day of gains.

Quest apps make measuring fun and easy with spatial awareness features and sound effects. The Tape Measure app has a wingspan ...

Berlin-based Quantune is trying to shrink laser spectrometers so that you can wear one on your wrist, and it just raised $9M ...

Based on these metrics and many more, DGX holds a Value grade of B, while PNTG has a Value grade of C. DGX has seen stronger estimate revision activity and sports more attractive valuation metrics ...

"High cortisol in a normal individual can be a sign of stress in your case," said Dr. Hatipoglu. "However, sometimes other ...

Significant stake increases in MGM Resorts, Viatris, US Bancorp, Markel Group, and Quest Diagnostics, with notable gains in ...

Quest Diagnostics and Elevance Health are broadening their partnership into four more states with the goal of making it ...